GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Kangji Medical Holdings Ltd (HKSE:09997) » Definitions » Beta

Kangji Medical Holdings (HKSE:09997) Beta : 0.78 (As of Jun. 01, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Kangji Medical Holdings Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2024-06-01), Kangji Medical Holdings's Beta is 0.78.


Kangji Medical Holdings Beta Historical Data

The historical data trend for Kangji Medical Holdings's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kangji Medical Holdings Beta Chart

Kangji Medical Holdings Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beta
Get a 7-Day Free Trial - - - - 0.68

Kangji Medical Holdings Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 0.50 0.68

Competitive Comparison of Kangji Medical Holdings's Beta

For the Medical Instruments & Supplies subindustry, Kangji Medical Holdings's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kangji Medical Holdings's Beta Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Kangji Medical Holdings's Beta distribution charts can be found below:

* The bar in red indicates where Kangji Medical Holdings's Beta falls into.



Kangji Medical Holdings Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.


Kangji Medical Holdings  (HKSE:09997) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Kangji Medical Holdings Beta Related Terms

Thank you for viewing the detailed overview of Kangji Medical Holdings's Beta provided by GuruFocus.com. Please click on the following links to see related term pages.


Kangji Medical Holdings (HKSE:09997) Business Description

Traded in Other Exchanges
Address
No. 1668 Chunjiang East Road, Tonglu Economic Development Zone, Zhejiang Province, Hangzhou, CHN
Kangji Medical Holdings Ltd is engaged in the production and sales of minimally invasive surgical instruments and accessories. The company offers a product portfolio to provide physicians and hospitals with one-shop and tailored surgical solutions for four surgical specialties OBGYN, general surgery, urology, and thoracic surgery. It manufactures and sells both disposable and reusable products. Its product portfolio includes disposable trocars, polymer ligation clips, disposable electrocoagulation forceps, and reusable trocar and forceps. It derives the majority of its revenue from Mainland China.
Executives
Butterfield Trust (asia) Limited 2301 Trustee
Fortune Spring Zm Aa Limited 2101 Beneficial owner
Yg Aa Limited 2201 Interest of corporation controlled by you
Bos Trustee Limited 2201 Interest of corporation controlled by you
Zhong Ming 2501 Other
Fortune Spring Yg B Limited 2101 Beneficial owner
Shentu Yinguang 2501 Other
Fortune Spring Zm B Limited 2101 Beneficial owner
Credit Suisse Trust Limited 2201 Interest of corporation controlled by you
Bonderman David 2201 Interest of corporation controlled by you
Coulter James George 2201 Interest of corporation controlled by you
Keyhole Holding Limited 2101 Beneficial owner
Tpg Asia Genpar Vii Advisors, Inc. 2201 Interest of corporation controlled by you
Tpg Asia Genpar Vii, L.p. 2201 Interest of corporation controlled by you
Tpg Group Holdings (sbs) Advisors, Inc. 2201 Interest of corporation controlled by you

Kangji Medical Holdings (HKSE:09997) Headlines

No Headlines